Tau levels in these regions were also associated with worsened cognitive performance in these mice, consistent with human studies linking cognitive decline and tau progression in AD (7–10), and further establishing a role of seizure-induced tau spread in overall disease progression. The gene discussed is MAPT; the disease is Alzheimer disease.